Carl Kraus

Carl Kraus

Chief Tech/Sci/R&D Officer at AQUESTIVE THERAPEUTICS, INC.

Net worth: 1 M $ as of 29/04/2024

Health Technology
Commercial Services
Consumer Services

Profile

Carl N.
Kraus
was the founder of Arrevus, Inc. founded in 2015, where he held the titles of Chairman, President & Chief Executive Officer from 2017 to 2021.
Currently, he is the Medical Director at i3 Research, Inc. and the Chief Medical Officer at Aquestive Therapeutics, Inc. since 2023.
Previously, he served as the Chief Medical Officer at Idera Pharmaceuticals, Inc. and Resilience Government Services, Inc. He was also the Chief Medical Officer at Aceragen, Inc. from 2021 to 2023.
Dr. Kraus received his undergraduate degree from Washington University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
06/03/2024 262,500 ( 0.29% ) 1 M $ 29/04/2024
16/01/2023 0 ( -.--% ) - $ 30/07/2023

Carl Kraus active positions

CompaniesPositionStart
AQUESTIVE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 25/06/2023
Chief Tech/Sci/R&D Officer -
All active positions of Carl Kraus

Former positions of Carl Kraus

CompaniesPositionEnd
ACERAGEN, INC. Chief Tech/Sci/R&D Officer 29/04/2023
Chief Executive Officer 30/10/2021
Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer -
See the detail of Carl Kraus's experience

Training of Carl Kraus

Washington University School of Medicine Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Carl Kraus's experience

Connections

23

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ACERAGEN, INC.

Health Technology

AQUESTIVE THERAPEUTICS, INC.

Health Technology

Private companies4

Commercial Services

Health Technology

Health Technology

Health Technology

See company connections